000			01658 a2200445 4500
005			20250511202554.0
264		0	_c19920318
008			199203s 0 0 eng d
022			_a0008-5472
040			_aNLM _beng _cNLM
100	1		_aList, J
245	0	0	_aCytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein). _h[electronic resource]
260			_bCancer research _cMar 1992
300			_a1123-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xcerebrospinal fluid
650	0	4	_aAdult
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInjections, Intraventricular
650	0	4	_aInterleukin-1 _xcerebrospinal fluid
650	0	4	_aInterleukin-2 _xadministration & dosage
650	0	4	_aInterleukin-6 _xcerebrospinal fluid
650	0	4	_aKiller Cells, Lymphokine-Activated
650	0	4	_aLeukocyte Count
650	0	4	_aLung Neoplasms
650	0	4	_aLymphocyte Subsets
650	0	4	_aMale
650	0	4	_aMelanoma _xcerebrospinal fluid
650	0	4	_aMeningeal Neoplasms _xcerebrospinal fluid
650	0	4	_aMiddle Aged
650	0	4	_aReceptors, Interleukin-2 _xmetabolism
650	0	4	_aTumor Necrosis Factor-alpha _xcerebrospinal fluid
700	1		_aMoser, R P
700	1		_aSteuer, M
700	1		_aLoudon, W G
700	1		_aBlacklock, J B
700	1		_aGrimm, E A
773	0		_tCancer research _gvol. 52 _gno. 5 _gp. 1123-8
999			_c1743768 _d1743768